In many cases, the authors observed that expression of galectin-4 was downregulated in patients with advanced stages of the disease and patients with good survival, leading to the hypothesis that galectin-4 may act as a tumor suppressor, at least for specific types of cancer (34). This evidence concerns the gene LGALS4 and neoplasm.